Histone deacetylase 3 supports endochondral bone formation by controlling cytokine signaling and matrix remodeling

被引:69
作者
Carpio, Lomeli R. [1 ,2 ]
Bradley, Elizabeth W. [3 ]
McGee-Lawrence, Meghan E. [4 ,5 ]
Weivoda, Megan M. [6 ]
Poston, Daniel D. [2 ,7 ]
Dudakovic, Amel [3 ]
Xu, Ming [8 ]
Tchkonia, Tamar [8 ]
Kirkland, James L. [8 ]
van Wijnen, Andre J. [2 ,3 ]
Oursler, Merry Jo [2 ,6 ]
Westendorf, Jennifer J. [2 ,3 ]
机构
[1] Mayo Clin, Mayo Grad Sch, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA
[4] Augusta Univ, Med Coll Georgia, Dept Cellular Biol & Anat, Augusta, GA 30912 USA
[5] Augusta Univ, Inst Regenerat & Reparat Med, Augusta, GA 30912 USA
[6] Mayo Clin, Dept Med, Div Endocrinol Diabet Metab & Nutr, Rochester, MN 55905 USA
[7] Creighton Univ, Omaha, NE 68102 USA
[8] Mayo Clin, Robert & Arlene Kogod Ctr Aging, Rochester, MN 55905 USA
关键词
NF-KAPPA-B; GROWTH-PLATE CHONDROGENESIS; HDAC INHIBITORS; INFLAMMATORY CYTOKINES; EXPRESSION; ACETYLATION; CARTILAGE; GENE; MASS; OSTEOCLASTOGENESIS;
D O I
10.1126/scisignal.aaf3273
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Histone deacetylase (HDAC) inhibitors are efficacious epigenetic-based therapies for some cancers and neurological disorders; however, each of these drugs inhibits multiple HDACs and has detrimental effects on the skeleton. To better understand how HDAC inhibitors affect endochondral bone formation, we conditionally deleted one of their targets, Hdac3, pre- and postnatally in type II collagen alpha 1 (Col2 alpha 1)-expressing chondrocytes. Embryonic deletion was lethal, but postnatal deletion of Hdac3 delayed secondary ossification center formation, altered maturation of growth plate chondrocytes, and increased osteoclast activity in the primary spongiosa. HDAC3-deficient chondrocytes exhibited increased expression of cytokine and matrix-degrading genes (II-6, Mmp3, Mmp13, and Saa3) and a reduced abundance of genes related to extracellular matrix production, bone development, and ossification (Acan, Col2a1, Ihh, and Col10a1). Histone acetylation increased at and near genes that had increased expression. The acetylation and activation of nuclear factor kappa B (NF-kappa B) were also increased in HDAC3- deficient chondrocytes. Increased cytokine signaling promoted autocrine activation of Janus kinase (JAK)-signal transducer and activator of transcription (STAT) and NF-kappa B pathways to suppress chondrocyte maturation, as well as paracrine activation of osteoclasts and bone resorption. Blockade of interleukin-6 (IL-6)-JAK-STAT signaling, NF-kappa B signaling, and bromodomain extraterminal proteins, which recognize acetylated lysines and promote transcriptional elongation, significantly reduced II-6 and Mmp13 expression in HDAC3-deficient chondrocytes and secondary activation in osteoclasts. The JAK inhibitor ruxolitinib also reduced osteoclast activity in Hdac3 conditional knockout mice. Thus, HDAC3 controls the temporal and spatial expression of tissue-remodeling genes and inflammatory responses in chondrocytes to ensure proper endochondral ossification during development.
引用
收藏
页数:15
相关论文
共 92 条
[1]
HDAC inhibitors as anti-inflammatory agents [J].
Adcock, I. M. .
BRITISH JOURNAL OF PHARMACOLOGY, 2007, 150 (07) :829-831
[2]
Deletion of histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control [J].
Bhaskara, Srividya ;
Chyla, Brenda J. ;
Amann, Joseph M. ;
Knutson, Sarah K. ;
Cortez, David ;
Sun, Zu-Wen ;
Hiebert, Scott W. .
MOLECULAR CELL, 2008, 30 (01) :61-72
[3]
Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases? [J].
Blanchard, F ;
Chipoy, C .
DRUG DISCOVERY TODAY, 2005, 10 (03) :197-204
[4]
Osteoclast precursors: cytokine-stimulated immunomodulators of inflammatory bone disease [J].
Boyce, Brendan F. ;
Schwarz, Edward M. ;
Xing, Lianping .
CURRENT OPINION IN RHEUMATOLOGY, 2006, 18 (04) :427-432
[5]
HISTONE DEACETYLASES IN BONE DEVELOPMENT AND SKELETAL DISORDERS [J].
Bradley, Elizabeth W. ;
Carpio, Lomeli R. ;
van Wijnen, Andre J. ;
McGee-Lawrence, Meghan E. ;
Westendorf, Jennifer J. .
PHYSIOLOGICAL REVIEWS, 2015, 95 (04) :1359-1381
[6]
Histone Deacetylase 3 Suppression Increases PH Domain and Leucine-rich Repeat Phosphatase (Phlpp)1 Expression in Chondrocytes to Suppress Akt Signaling and Matrix Secretion [J].
Bradley, Elizabeth W. ;
Carpio, Lomeli R. ;
Westendorf, Jennifer J. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (14) :9572-9582
[7]
Histone deacetylase inhibitors as suppressors of bone destruction in inflammatory diseases [J].
Cantley, Melissa D. ;
Bartold, Peter M. ;
Fairlie, David P. ;
Rainsford, K. D. ;
Haynes, David R. .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2012, 64 (06) :763-774
[8]
Duration of nuclear NF-κB action regulated by reversible acetylation [J].
Chen, LF ;
Fischle, W ;
Verdin, E ;
Greene, WC .
SCIENCE, 2001, 293 (5535) :1653-1657
[9]
Generation of a transgenic mouse model with chondrocyte-specific and tamoxifen-inducible expression of Cre recombinase [J].
Chen, Mo ;
Lichtler, Alexander C. ;
Sheu, Tzong-Jen ;
Xie, Chao ;
Zhang, Xinping ;
O'Keefe, Regis J. ;
Chen, Di .
GENESIS, 2007, 45 (01) :44-50
[10]
Alleviation of osteoarthritis by Trichostatin A, a histone deacetylase inhibitor, in experimental osteoarthritis [J].
Chen, Wei-Ping ;
Bao, Jia-Peng ;
Hu, Peng-Fei ;
Feng, Jie ;
Wu, Li-Dong .
MOLECULAR BIOLOGY REPORTS, 2010, 37 (08) :3967-3972